EWM
MDGL icon

Edge Wealth Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Edge Wealth Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-29
Closed -$2K – 476
2015
Q3 		$2K Hold
29
– – ﹤0.01% 394
2015
Q2 		$2K Buy
+29
New +$2.43K ﹤0.01% 389

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Edge Wealth Management's MDGL Position: Q4 2015 in Review

Edge Wealth Management sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2015, closing a stake of 29 shares — an estimated $2K sold.

Edge Wealth Management first reported a position in MDGL in Q2 2015 and held it in 2 quarters. The position peaked at $2K in Q3 2015. 75 funds tracked by Wall St. Rank hold MDGL as of Q4 2015.

  • Edge Wealth Management reported no remaining Madrigal Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Edge Wealth Management sold 29 Madrigal Pharmaceuticals shares in Q4 2015, an estimated $2K.
  • Edge Wealth Management first reported a position in Madrigal Pharmaceuticals in Q2 2015 and held it in 2 quarters.
  • Edge Wealth Management's Madrigal Pharmaceuticals position peaked at $2K in Q3 2015.
  • 75 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2015.

Based on Edge Wealth Management's 13F filing for Q4 2015, filed 11 Jan 2016.